|
HS Code |
262199 |
| Chemical Name | 2,6-Dichloro-4-Bromopyrimidine |
| Cas Number | 3430-18-0 |
| Molecular Formula | C4HBrCl2N2 |
| Molecular Weight | 227.88 |
| Appearance | White to light yellow crystalline powder |
| Melting Point | 85-87°C |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Purity | Typically ≥98% |
| Density | 1.95 g/cm³ |
| Smiles | C1=NC(=C(N=C1Cl)Br)Cl |
| Storage Conditions | Store in a cool, dry place and keep container tightly closed |
As an accredited 2,6-Dichloro-4-Bromopyrimidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2,6-Dichloro-4-Bromopyrimidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Living in a world that runs on advanced science and technology, I have come to appreciate the behind-the-scenes efforts that go into producing chemicals that quietly support innovation in pharmaceuticals and materials research. Among these, 2,6-Dichloro-4-Bromopyrimidine earns its place as a strategic building block for anyone working in organic synthesis, whether you are deep in a university lab or part of an industrial research team looking to drive new discoveries.
The real story of chemicals like this pyrimidine derivative unfolds in the lab and in the factory. The molecular structure, marked by two chlorine atoms at the 2 and 6 positions and a bromine at the 4 position on the pyrimidine ring, offers far more than a simple variation on a parent molecule. These small tweaks to a chemical backbone give researchers tailor-made handles for precision chemistry. In practice, chemists value 2,6-Dichloro-4-Bromopyrimidine as a starting point to create more complex molecules — a job it does more efficiently due to the combined reactivity of its halogens.
When you want to introduce functional groups at specific points on a pyrimidine ring, you often face the challenge of unwanted side reactions and low yields. By choosing a compound that already incorporates two chlorines and a bromine, like the one on this page, researchers save time and gain more control over the direction of their reaction. The combination of halogens offers opportunities to run selective substitution reactions; experienced chemists have found that the bromine atom reacts at a different rate compared to chlorine, allowing for stepwise modification. In a field that values precision, that kind of selectivity brings real rewards.
I have come to expect certain things from a quality intermediate. Purity stands at the top of the list — even a few tenths of a percent impurity can derail a synthetic step further down the line. With 2,6-Dichloro-4-Bromopyrimidine, purity levels typically reach more than 98%, which gives researchers confidence in their reactions and results. I remember a case where just a 1% impurity led to unwanted byproducts, pushing back a project timeline by weeks. Reliable sources pay close attention to the consistency and verification of each batch, aiming to avoid such setbacks.
The product's appearance is usually a pale yellow to off-white crystalline powder, and it remains stable enough for extended storage at room temperature if kept out of direct sunlight and away from moisture. The melting point provides clues about the identity and purity of the compound; users have reported values in the range of 90–94°C, which matches expectations based on published literature. That consistency is not a luxury — for someone running a multi-step synthesis, knowing the intermediate matches the right physical properties gives peace of mind.
The versatility of this compound shines in practical applications. Medicinal chemists have found that introducing pyrimidine derivatives into drug candidates often enhances their bioactivity, selectivity, or metabolic stability. In my own experience working alongside medicinal chemists, I have seen 2,6-Dichloro-4-Bromopyrimidine used to create kinase inhibitors — the kind of molecules that can slow or block signals involved in cancer or autoimmune disease. The selective reactivity of the halogen groups allows researchers to substitute them with amines, alkoxy groups, or other moieties by conditions that a well-equipped research lab can handle.
These substitution reactions can proceed either by direct nucleophilic aromatic substitution or through palladium-catalyzed cross-coupling, such as Suzuki or Buchwald-Hartwig reactions. For someone running a synthetic campaign, this flexibility speeds up route exploration and SAR (structure-activity relationship) studies. In one real-world example, a colleague used this compound to construct a library of compounds with small modifications at the 4-position, enabling rapid screening for antiviral activity. The efficiency came not from special equipment, but from the built-in reactivity gained by the chlorine and bromine pattern.
Many intermediates based on pyrimidine cores line the shelves of chemical catalogs, each sporting a unique pattern of halogen, alkyl, or other substituents. The difference lies in the rates at which these groups can be exchanged in reactions and the pathways those options open up for synthesis. For example, the monohalogenated pyrimidines like 2-chloropyrimidine or 4-bromopyrimidine serve as useful starting materials but don't support the same level of sequential functionalization. They often require more separate steps, or harsher conditions to push the chemistry forward.
Having both chlorines and a bromine on the same molecule gives 2,6-Dichloro-4-Bromopyrimidine an edge. In practical terms, I have seen teams exploit the higher reactivity of the bromine to carry out cross-coupling reactions first, reserving the less reactive chlorines for later modifications. This order often matters, as the conditions used can affect overall yield and streamline purification steps. I recall one project comparing a set of related compounds, and this intermediate consistently demonstrated cleaner reaction profiles — less time at the bench, more time analyzing promising leads.
Its versatility pairs well with demands for scalable synthesis. As drug development moves from early discovery to pre-clinical studies, demand for multi-gram or even kilogram amounts rises. Feedback from colleagues in process development emphasized that this compound, with its predictable chemical behavior and relatively straightforward isolation, reduced challenges in scale-up. The fewer side products form, the easier it becomes to purify both the intermediate and the final compounds, ultimately lowering the cost and improving access for project teams and partners.
I have also seen the limitations that come with chemicals like 2,6-Dichloro-4-Bromopyrimidine. While its versatility is a key strength, some users run into solubility challenges, especially in polar solvents or water-based media. Solutions often require extra optimization in the solvent systems or temperature control to keep the material in solution for reactions. These aspects introduce complexity and sometimes call for extra experimentation. But the learning that comes from troubleshooting leads to better protocols, greater yields, and more robust synthesis over time.
Anyone working with halogenated pyrimidines also faces health and safety questions. Like many organic intermediates that incorporate multiple halogens, this compound requires careful handling. Strict protocols minimize risk: using a well-ventilated fume hood, wearing gloves and goggles, and carefully segregating waste streams. In my experience, emphasizing safety not only protects workers but also builds trust among team members — and that trust makes it easier for scientists to share notes, technique improvements, or procedural warnings with each other, leading to better science all around.
Waste management in halogenated chemistry remains an issue that the industry can’t ignore. Disposal protocols continue to evolve as environmental regulations tighten in many countries. Labs and manufacturing sites invest more in recovery and recycling systems so halogen-containing byproducts don’t reach the environment or water systems. In my view, developments in green chemistry and new catalytic processes offer promising approaches. Several academic teams have already demonstrated milder and more selective couplings, which not only improve efficiency but also reduce hazardous waste. Experience shows that sustainable practices appeal both to scientists and to consumers interested in the environmental footprint of modern chemistry.
The uses of 2,6-Dichloro-4-Bromopyrimidine extend well beyond academic curiosity. Its chemistry underpins real momentum in drug discovery, agrochemical innovation, and even materials development. As pharmaceutical teams create new candidates for trials, they often need new heterocyclic scaffolds with specific patterns of substitution. This compound delivers value by accelerating that build-test-learn cycle. It’s rewarding to see a chemical you ordered contribute to animal studies or even clinical lead nomination. The same goes for agrochemical projects, where speed and selectivity in synthetic chemistry help deliver safer and more potent products to the market quickly.
Materials science researchers also find value in pyrimidine derivatives. Polymers, specialty coatings, and electronic materials sometimes rely on unique patterns of halogenation to deliver targeted conductivity, durability, or reactivity. I spoke with a team working on organic semiconductors, and their use of halopyrimidines allowed for better charge transport in thin-film devices. These successes build on the foundation that well-characterized intermediates like 2,6-Dichloro-4-Bromopyrimidine supply, bridging the gap between bench research and functional products.
According to patents and peer-reviewed articles, this compound features strongly in syntheses of kinase inhibitors, antihypertensive agents, antivirals, and agricultural fungicides. The published literature highlights its role in Suzuki couplings, where the aryl bromide participates easily with aryl or alkenyl boronic acids. Data from chemical suppliers show that demand for this compound has grown over the past decade alongside increased interest in pyrimidine-containing drug scaffolds. Prices fluctuate with demand, but the improving supply chain in major research regions keeps the product accessible for discovery and scale-up alike.
Beyond drug discovery, chemical catalog data shows its presence in libraries targeting herbicidal and fungicidal lead compounds. The underlying chemistry matches reports from researchers who identified increased activity in molecules developed from pyrimidine intermediates modified at the 2, 4, and 6 positions. Researchers seek out 2,6-Dichloro-4-Bromopyrimidine for the strategic flexibility its pattern of halogens unlocks, not just because it is a variant of a common core.
Experience gives perspective on what makes a chemical intermediate especially valuable to scientists. Easy-to-use, well-characterized products save time, reduce troubleshooting, and enable more creative chemistry. The best suppliers collaborate closely with researchers, updating protocols, sharing improved synthesis or purification methods, and investing in analytical capabilities for robust lot-to-lot consistency. Regular feedback loops between producers and users lead to process refinements, less waste, and greater satisfaction for everyone involved.
Continuous innovation moves the field forward. Advances in transition-metal catalysis now allow for milder reaction conditions — palladium- or nickel-catalyzed couplings require less energy input and offer greater selectivity, broadening the scope of what can be built from core fragments like this one. As more teams publish their protocols and structure-activity relationships based on this intermediate, shared knowledge further lowers barriers for entry, making it easier for newcomers and experts alike to adopt best practices.
From my vantage point, the success stories that shine brightest often come from projects where people and products meet at the intersection of reliability, flexibility, and stewardship. When the basics are in place — a clean, well-characterized intermediate, open lines of communication, and a safety-minded team — chemistry moves beyond “making products” and starts building the future. 2,6-Dichloro-4-Bromopyrimidine is not just another entry in a reagent catalog. To those on the frontlines of discovery, it’s the upstream step that allows creative thinking to flourish, powered by a foundation of rigorous science and shared experience.
I have watched this compound’s reputation grow alongside the needs of the research world. Its balance of reactivity and selectivity, supported by ever-better production and quality standards, continues to equip scientists both in academic labs and industry. By demanding higher purity, more transparency in supplier communications, and constant improvements in environmental impact, researchers and their partners help ensure that chemistry keeps unlocking new solutions for health, agriculture, and technology.
No chemical intermediate acts in isolation. Each batch shipped to a laboratory feeds into a bigger effort, part of a workflow that stretches from early brainstorms to published findings or patented processes. I recall times when vendors provided detailed certificates of analysis and open responses to questions about trace impurities or batch variation. Those conversations gave teams the confidence to push forward, even on tight timelines. The great advantage of products like 2,6-Dichloro-4-Bromopyrimidine comes not only from what sits inside the bottle but from the network of trust, transparency, and hard-won experience that surrounds it.
Zeroing in on customer feedback, listening to the pains and successes of scientists, and building flexible, scalable supply chains — this has become the norm for progressive producers. The result is a product that helps teams move past repetitive troubleshooting and focus on what matters: designing new molecules, understanding structure-activity relationships, and delivering innovative solutions to end users. The trick is to keep raising the bar for quality while making it easier for researchers everywhere to access these valuable building blocks.
As I reflect on my time in labs and collaborative spaces, the story of 2,6-Dichloro-4-Bromopyrimidine feels familiar. It represents more than a chemical — for many researchers it stands as a chance to reimagine what synthesis and discovery can achieve when everyone involved pursues accuracy, safety, and effective communication. It’s a journey shaped by hands-on troubleshooting, transparent dialogue, and the willingness to keep improving. That experience, embodied in a single crystalline powder, drives progress today and tomorrow.